Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine
{{output}}
Introduction: The therapeutic landscape for metastatic prostate cancer has expanded substantially over the last decade, yet treatment selection remains predominantly driven by clinical parameters rather than validated molecular p... ...
